Sean Pinney

TL;DR: Cardiovascular disease (CVD) including coronary artery disease, atrial fibrillation, and heart failure, was more prevalent in patients with higher troponin concentrations, as were hypertension and diabetes.

TL;DR: In this patient cohort with cardiac vasculopathy, treatment with rapamycin slowed disease progression probably by its antiproliferative and antimigratory effects.

TL;DR: Risk factor analysis suggests that a number of patient-related factors contribute to the risk of thrombosis, and that survival remains high (80% at 1 year) with the HMII LVAD.

TL;DR: An international, multicenter cohort study including 7 hospitals in New York City and Milan of hospitalized patients with laboratory-confirmed COVID-19 who had undergone transthoracic echocardiographic (TTE) and electrocardiographic evaluation during their index hospitalization found cardiac structural abnormalities were present in nearly two-thirds of patients with myocardial injury.

TL;DR: As the use of this technology continues to evolve rapidly, it is important to understand the indications and contraindications; the logistics of ECMO initiation, management, and weaning; the general infrastructure of the program; and ethical considerations, areas of uncertainty, and future directions.